FB
Publications
46
Views
22,528
Downloads
2,191
Supervised works
0
Items per page
1 - 46 of 46
Title Published in Access level OA Policy Year Views Downloads
Reduced sclerostin expression in human atherosclerotic plaques links to ischemic strokeJournal of the American Heart Association. Cardiovascular and cerebrovascular disease
accessLevelPublic
2024 56 20
Circulating GDF11 exacerbates myocardial injury in mice and associates with increased infarct size in humansCardiovascular research
accessLevelPublic
2023 45 18
Epitope of antiphospholipid antibodies retrieved from peptide microarray based on R39-R43 of β2-glycoprotein IResearch and practice in thrombosis and haemostasis
accessLevelPublic
2022 162 183
High antibody titers against apolipoprotein-A1 in NAFLD: a possible link between fatty liver disease and CVD?90th European Atherosclerosis Society (EAS) congress
2022 139 0
Single-cell analysis uncovers osteoblast factor growth differentiation factor 10 as mediator of vascular smooth muscle cell phenotypic modulation associated with plaque rupture in human carotid artery diseaseInternational journal of molecular sciences
accessLevelPublic
2022 168 181
Single-Cell RNA-Seq Reveals a Crosstalk between Hyaluronan Receptor LYVE-1-Expressing Macrophages and Vascular Smooth Muscle CellsCells
accessLevelPublic
2022 184 183
NLRP3 inflammasome activation controls vascular smooth muscle cells phenotypic switch in atherosclerosisInternational journal of molecular sciences
accessLevelPublic
2021 246 188
Autoantibodies directed against apolipoprotein-A1 as a potential contributor to Non-Alcoholic Fatty Liver Disease89th Europen Society of Atherosclerosis (EAS)
2021 122 0
Follicular regulatory helper T cells control the response of regulatory B cells to a high-cholesterol dietCardiovascular Research
accessLevelPublic
2021 183 92
Anti-Apolipoprotein A-1 IgG Influences Neutrophil Extracellular Trap Content at Distinct Regions of Human Carotid PlaquesInternational Journal of Molecular Sciences
accessLevelPublic
2020 219 98
Cardiotrophin-1 Deficiency Abrogates Atherosclerosis ProgressionScientific Reports
accessLevelPublic
2020 198 167
Atherosclerotic plaque vulnerability is increased in mouse model of lupusScientific Reports
accessLevelPublic
2020 301 185
Cardiomyocyte-Specific JunD Overexpression Increases Infarct Size following Ischemia/Reperfusion Cardiac Injury by Downregulating Sirt3Thrombosis and Haemostasis
accessLevelRestricted
2020 217 0
Prognostic and therapeutic considerations of antibodies against c‐ter apolipoprotein A‐1 in the general populationClinical & translational immunology
accessLevelPublic
2020 177 105
Platelet-to-lymphocyte ratio at the time of carotid endarterectomy is associated with acute coronary syndrome occurrenceJournal of cardiovascular medicine
accessLevelRestricted
2020 196 0
Vitamin D receptor is expressed within human carotid plaques and correlates with pro-inflammatory M1 macrophagesVascular pharmacology
2016 533 0
Treatment with anti-RANKL antibody reduces infarct size and attenuates dysfunction impacting on neutrophil-mediated injuryJournal of Molecular and Cellular Cardiology
accessLevelRestricted
2016 565 1
Treatment with the GPR55 antagonist CID16020046 increases neutrophil activation in mouse atherogenesisThrombosis and haemostasis
accessLevelRestricted
2016 702 1
Anti-ApoA-1 IgG serum levels predict worse post-stroke outcomesEuropean journal of clinical investigation
accessLevelRestricted
2016 597 6
Anti-apolipoprotein A-1 auto-antibodies as active modulators of atherothrombosisThrombosis and haemostasis
accessLevelPublic
2016 719 570
Intraplaque Expression of C-Reactive Protein Predicts Cardiovascular Events in Patients with Severe Atherosclerotic Carotid Artery StenosisMediators of Inflammation
accessLevelPublic
2016 473 180
Leptin/adiponectin ratio predicts post-stroke neurological outcomeEuropean journal of clinical investigation
accessLevelRestricted
2015 561 1
Serum osteopontin levels are upregulated and predict disability after an ischaemic strokeEuropean journal of clinical investigation
accessLevelRestricted
2015 607 0
Genetic deletion of the adaptor protein p66Shc increases susceptibility to short-term ischaemic myocardial injury via intracellular salvage pathwaysEuropean heart journal
accessLevelRestricted
2015 636 2
Treatment with KLEPTOSE® CRYSMEB reduces mouse atherogenesis by impacting on lipid profile and Th1 lymphocyte responseVascular pharmacology
accessLevelRestricted
2015 712 0
Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathwaysVascular pharmacology
accessLevelRestricted
2015 812 4
Gastric bypass in morbid obese patients is associated with reduction in adipose tissue inflammation via N-oleoylethanolamide (OEA)-mediated pathwaysThrombosis and haemostasis
accessLevelRestricted
2015 767 0
Treatment with sulphated galactan inhibits macrophage chemotaxis and reduces intraplaque macrophage content in atherosclerotic miceVascular pharmacology
accessLevelRestricted
2015 586 0
Anti-apoA-1 auto-antibodies increase mouse atherosclerotic plaque vulnerability, myocardial necrosis and mortality triggering TLR2 and TLR4Thrombosis and haemostasis
accessLevelRestricted
2015 604 5
Treatment with Evasin-3 abrogates neutrophil-mediated inflammation in mouse acute pancreatitisEuropean journal of clinical investigation
accessLevelRestricted
2014 631 0
Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic miceThrombosis and haemostasis
accessLevelRestricted
2014 757 0
Treatment with the CC chemokine-binding protein Evasin-4 improves post-infarction myocardial injury and survival in miceThrombosis and haemostasis
accessLevelRestricted
2013 724 0
Treatment with Evasin-3 reduces atherosclerotic vulnerability for ischemic stroke, but not brain injury in miceJournal of cerebral blood flow and metabolism
accessLevelRestricted
2013 695 0
Role of NADPH oxidase isoforms NOX1, NOX2 and NOX4 in myocardial ischemia/reperfusion injuryJournal of Molecular and Cellular Cardiology
accessLevelRestricted
2013 617 0
Fatty acid amide hydrolase deficiency enhances intraplaque neutrophil recruitment in atherosclerotic miceArteriosclerosis, thrombosis, and vascular biology
accessLevelRestricted
2013 473 1
The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaquesEuropean heart journal
accessLevelRestricted
2012 692 0
Chemokine CCL5/RANTES inhibition reduces myocardial reperfusion injury in atherosclerotic miceJournal of Molecular and Cellular Cardiology
accessLevelRestricted
2010 695 0
CB(2) cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusionJournal of Molecular and Cellular Cardiology
accessLevelRestricted
2009 754 0
HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trialAIDS
accessLevelRestricted
2009 632 0
Statins inhibit C-reactive protein-induced chemokine secretion, ICAM-1 upregulation and chemotaxis in adherent human monocytesRheumatology
accessLevelRestricted
2009 624 0
Regulation and possible role of endocannabinoids and related mediators in hypercholesterolemic mice with atherosclerosisAtherosclerosis
accessLevelRestricted
2009 608 0
Tumor necrosis factor-alpha (TNF-alpha) induces integrin CD11b/CD18 (Mac-1) up-regulation and migration to the CC chemokine CCL3 (MIP-1alpha) on human neutrophils through defined signalling pathwaysCellular signalling
accessLevelRestricted
2008 682 0
C-reactive protein (CRP) induces chemokine secretion via CD11b/ICAM-1 interaction in human adherent monocytesJournal of leukocyte biology
accessLevelRestricted
2008 616 0
CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathwaysAmerican journal of physiology. Heart and circulatory physiology
accessLevelRestricted
2008 601 0
A novel RANTES antagonist prevents progression of established atherosclerotic lesions in miceArteriosclerosis, thrombosis, and vascular biology
accessLevelRestricted
2008 657 0
Atorvastatin treatment and vaccination efficacyJournal of clinical pharmacology
accessLevelRestricted
2007 583 0
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack